In this issue:
Perioperative therapy is crucial for limited-stage SCEC
Palliative EBRT relieves dysphagia in incurable ESCC
CAFs correlate with response to neoadjuvant therapy in EAC
The incidence of lymph node metastasis in early-stage EAC
Nivolumab combo durably improves quality-adjusted survival in inoperable EAC
Improved quality-adjusted survival with nivolumab ± ipilimumab in ESCC
Perioperative FLOT boosts survival in locally advanced malignancy
MATTERHORN: Survival benefit to durvalumab in GEJ cancer
Reduced nutritional status during NACT impacts RFS
EV-202 shows anti-tumour activity for EV in ESCC
Please login below to download this issue (PDF)